JAK2 and coronary artery disorder: Whereas, in JAK2 promoter region, mean percentage methylation in CAD patients was found to be −3.954 ± 0.3101 (p < 0.001) as compared to mean percentage methylation of 1.124 ± 0.5045 in control samples.